Suzhou Fengbei Biotech Stock Co., Ltd. (SHA:603334)
China · Delayed Price · Currency is CNY 54.75
+1.23 (2.30%)
Feb 13, 2026, 3:00 PM CST
SHA:603334 Market Cap
SHA:603334 has a market cap or net worth of 7.86 billion as of February 13, 2026.
Market Cap
7.86B
Enterprise Value
8.12B
Revenue
2.81B
Ranking
n/a
PE Ratio
38.33
Stock Price
54.75
Market Cap Chart
Since November 5, 2025, SHA:603334's market cap has decreased from 9.58B to 7.86B, a decrease of -17.99%. That is a compound annual growth rate of -51.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 7.68B | 28.04% |
| Dec 31, 2025 | 6.00B | -37.39% |
| Nov 5, 2025 | 9.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangxi Fushine Pharmaceutical | 8.69B |
| Anhui Huaheng Biotechnology | 8.67B |
| Acrobiosystems | 8.45B |
| Nanjing Vazyme Biotech | 8.31B |
| Zhejiang Ausun Pharmaceutical | 8.05B |
| Wuhan Keqian Biology Co.,Ltd | 7.60B |
| R&G PharmaStudies | 7.43B |
| GemPharmatech | 7.15B |